1.Development of Advanced Atherosclerotic Plaque by Injection of Inflammatory Proteins in a Rabbit Iliac Artery Model.
Jung Sun KIM ; Seul Gee LEE ; Jaewon OH ; Sungha PARK ; Se Il PARK ; Sung Yu HONG ; Sehoon KIM ; Sang Hak LEE ; Young Guk KO ; Donghoon CHOI ; Myeong Ki HONG ; Yangsoo JANG
Yonsei Medical Journal 2016;57(5):1095-1105
PURPOSE: Appropriate animal models of atherosclerotic plaque are crucial to investigating the pathophysiology of atherosclerosis, as well as for the evaluation of the efficacy and safety of vascular devices. We aimed to develop a novel animal model that would be suitable for the study of advanced atherosclerotic lesions in vivo. MATERIALS AND METHODS: Atherosclerotic plaque was induced in 24 iliac arteries from 12 rabbits by combining a high cholesterol diet, endothelial denudation, and injection into the vessel wall with either saline (n=5), olive oil (n=6), or inflammatory proteins [n=13, high-mobility group protein B1 (HMGB1) n=8 and tumor necrosis factor (TNF)-α n=5] using a Cricket™ Micro-infusion catheter. Optical coherence tomography (OCT) was performed to detect plaque characteristics after 4 weeks, and all tissues were harvested for histological evaluation. RESULTS: Advanced plaque was more frequently observed in the group injected with inflammatory proteins. Macrophage infiltration was present to a higher degree in the HMGB1 and TNF-α groups, compared to the oil or saline group (82.1±5.1% and 94.6±2.2% compared to 49.6±14.0% and 46.5±9.6%, p-value<0.001), using RAM11 antibody staining. On OCT, lipid rich plaques were more frequently detected in the inflammatory protein group [saline group: 2/5 (40%), oil group: 3/5 (50%), HMGB1 group: 6/8 (75%), and TNF-α group: 5/5 (100%)]. CONCLUSION: These data indicate that this rabbit model of atherosclerotic lesion formation via direct injection of pro-inflammatory proteins into the vessel wall is useful for in vivo studies investigating atherosclerosis.
Animals
;
Cholesterol, Dietary/administration & dosage
;
*Disease Models, Animal
;
Endothelium/surgery
;
HMGB1 Protein/*adverse effects
;
Iliac Artery/diagnostic imaging/pathology/surgery
;
Injections, Intra-Arterial
;
Macrophages
;
Male
;
Olive Oil/adverse effects
;
Plaque, Atherosclerotic/*chemically induced/diagnostic imaging/pathology
;
Rabbits
;
Sodium Chloride/adverse effects
;
Tomography, Optical Coherence
;
Tumor Necrosis Factor-alpha/*adverse effects
2.Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Hae Rim KIM ; Young Sun LEE ; Hyung Joon YIM ; Hyun Joo LEE ; Ja Young RYU ; Hyun Jung LEE ; Eileen L. YOON ; Sun Jae LEE ; Jong Jin HYUN ; Sung Woo JUNG ; Ja Seol KOO ; Rok Sun CHOUNG ; Sang Woo LEE ; Jai Hyun CHOI
Clinical and Molecular Hepatology 2013;19(4):417-420
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
Bilirubin/blood
;
Creatinine/blood
;
Electrocardiography
;
Fatal Outcome
;
Hepatorenal Syndrome/*drug therapy
;
Humans
;
Intestinal Mucosa/pathology
;
Intestines/surgery
;
Liver Cirrhosis/diagnosis/therapy
;
Lypressin/adverse effects/*analogs & derivatives/therapeutic use
;
Male
;
Middle Aged
;
Necrosis/*chemically induced/surgery
;
Tomography, X-Ray Computed
;
Vasoconstrictor Agents/*adverse effects/*therapeutic use